Victory Capital Management Inc Fennec Pharmaceuticals Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$5.43 - $9.39 $50,135 - $86,697	-9,233 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$4.89 - $8.1 $14,156 - $23,449	2,895 Added 45.68%	9,233 $55,000
Q4 2019 Feb 06, 2020	SELL	$4.25 - $6.49 $12,584 - $19,216	-2,961 Reduced 31.84%	6,338 $41,000
Q4 2019 Feb 04, 2020	SELL	$4.25 - $6.49 $204 - $311	-48 Reduced 0.51%	9,299 $62,000
Q3 2019 Nov 12, 2019	BUY	$3.85 - $4.95 $35,985 - $46,267	9,347 New	9,347 $45,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $160M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.